We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

125 hedge funds and large institutions have $434M invested in G1 Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

29% more capital invested

Capital invested by funds: $336M → $434M (+$97.4M)

6% more funds holding

Funds holding: 118 → 125 (+7)

9% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

64% less call options, than puts

Call options by funds: $2.54M | Put options by funds: $7.12M

Holders
125
Holders Change
+7
Holders Change %
+5.93%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
47
Reduced
43
Closed
10
Calls
$2.54M
Puts
$7.12M
Net Calls
-$4.58M
Net Calls Change
-$2.81M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$5.53M
2
Invesco
Invesco
Georgia
+$5.2M
3
N
Nuveen
North Carolina
+$4.46M
4
BlackRock
BlackRock
New York
+$3.93M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
+$3.58M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$50.3M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$26.1M
3
BG
Bellevue Group
Switzerland
-$8.34M
4
HA
HHLR Advisors
Cayman Islands
-$7.09M
5
Millennium Management
Millennium Management
New York
-$6.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
26
Raymond James & Associates
Florida
$2.61M -$292K -19,564 -12%
Millennium Management
27
Millennium Management
New York
$2.56M -$6.18M -413,700 -74%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.37M -$130K -8,680 -6%
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$2.3M +$71.5K +4,784 +4%
Los Angeles Capital Management
30
Los Angeles Capital Management
California
$2.13M -$319K -21,340 -15%
BCM
31
Burrage Capital Management
Massachusetts
$2.12M -$1.66M -110,889 -49%
PP
32
PDT Partners
New York
$1.78M -$616K -41,199 -29%
Man Group
33
Man Group
United Kingdom
$1.74M +$496K +33,200 +52%
Barclays
34
Barclays
United Kingdom
$1.66M +$1.09M +72,854 +378%
Ameriprise
35
Ameriprise
Minnesota
$1.61M +$264K +17,694 +25%
CS
36
Credit Suisse
Switzerland
$1.29M -$236K -15,820 -18%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.25M -$22.4K -1,500 -2%
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.16M +$20.9K +1,400 +2%
CA
39
CHI Advisors
New York
$1.11M -$329K -22,000 -26%
Arrowstreet Capital
40
Arrowstreet Capital
Massachusetts
$992K +$824K +55,145 New
Massachusetts Financial Services
41
Massachusetts Financial Services
Massachusetts
$988K -$8.22K -550 -1%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$968K +$85.4K +5,718 +12%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$927K – – –
DekaBank Deutsche Girozentrale
44
DekaBank Deutsche Girozentrale
Germany
$845K +$508K +34,000 +264%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$840K -$86.7K -5,800 -11%
Wells Fargo
46
Wells Fargo
California
$758K +$179K +11,952 +40%
BC
47
Birchview Capital
Vermont
$720K – – –
RJFSA
48
Raymond James Financial Services Advisors
Florida
$711K -$181K -12,107 -23%
VRS
49
Virginia Retirement Systems
Virginia
$693K +$575K +38,500 New
BWA
50
BDO Wealth Advisors
Florida
$634K – – –
1
2
3 4 5

GTHX Hedge Fund Activity: Q4 2020 in Review

125 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q4 2020, worth a combined $434M — up 29% from $336M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new GTHX positions and 10 closed out — a net gain of 7 holders — while 47 added to existing stakes and 43 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $5.53M. The largest seller was Fidelity Investments, cutting an estimated $50.3M.

  • 125 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q4 2020, up from 118 in Q3 2020.
  • Funds reported $434M of G1 Therapeutics, Inc. Common Stock stock for Q4 2020, up 29% quarter-over-quarter.
  • 17 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q4 2020 and 10 closed out, a net change of +7 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q4 2020 was Two Sigma Advisers, an estimated $5.53M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q4 2020 was Fidelity Investments, an estimated $50.3M sold.

Based on aggregated 13F filings for Q4 2020.